Metrics Contract Services Adopts New Name and Logo - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Metrics Contract Services Adopts New Name and Logo

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 8

Metrics Contract Services, a contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.

The company is unveiling a new brand look that more clearly identifies Metrics Contract Services as being part of the Mayne Pharma global family, according to a company press release.

“We know from market research that Metrics enjoys a great deal of positive brand equity with clients, who associate us with attributes such as quality, reliability, responsiveness and honesty,” said John S. Ross, executive vice president in the press release. “The new Metrics Contract Services brand identity conveys that we’re the same people, delivering the same quality experiences for clients -- and that now we’re backed by a global pharmaceutical organization with the added resources to deliver even more capabilities.”

With its more descriptive suffix, the name Metrics Contract Services better communicates an ability to deliver a full range of outsourced pharmaceutical formulation development and manufacturing capabilities, Ross said. The new logo--an adaptation of Mayne Pharma’s logo--reflects that Metrics Contract Services is a key component of the global pharmaceutical company, the company reports.

Source: Metrics Contract Services


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here